We are only 3 days away from DIA 2024! Visit the Vivpro Corp team at booth #1231 for engaging discussions and enjoy freshly made warm churros! Are you attending? Leave us a comment! ⬇ We would love to connect. 😁 #Vivpro #RIA #DIA2024 #MorePowerToYou #BioTech #Pharma #RegulatoryStrategy #RegulatoryAffairs #ClinPharm #AiinPharma
Vivpro Corp’s Post
More Relevant Posts
-
MAbSilico prioritizes cross-specificity. We assess inter-molecular and inter-species reactivity, minimizing side effects and preparing for pre-clinical trials. Discover more: 🌐 mabsilico.com #DrugDiscovery #BioTechs #Pharma #Insilico
To view or add a comment, sign in
-
Progressing from binders to leads, MaBSilico orchestrates a symphony of optimization. Affinity, manufacturability, off-targets, and diversity to design the best candidates. These leads are poised for functional validation and pre-clinical studies. Learn more about our process: 🌐 mabsilico.com #DrugDiscovery #BioTechs #Pharma #Insilico
To view or add a comment, sign in
-
So you’re looking for GenAI use cases in biopharma… … but you missed our webinar. 😞 Don’t worry, we’ve got you covered. 😉 Join our expert AI panel of Alex Jijie | Digitalya OPS, Jessica Ingram | Camino, and Manuel Mitola, MBA on demand. In this free webinar recording, you will learn all about how you can start with GenAI today. Watch here 👉 https://brnw.ch/21wL66H Psst...👂 We had an amazing Q&A session at the end of the webinar! Check out some of the most pressing questions with answers in the comments below. #magnoliadxp #pharma #biotech #biopharma #genai
To view or add a comment, sign in
-
Clinical Innovation on Environmental Sustainability and Patient-Centric Sampling / Clinical Innovation Manager, Novartis
Looking forward presenting in 2 weeks, for the first time externally, our work on shipments with clinical samples, their carbon footprint, and how we can reduce (and get savings along!)... The title of that Symposium is "Challenges and Solutions of Sample Management": I believe that a challenge (to come) is how we will operate by 2030 in a context of targeted carbon-neutrality (scopes 1, 2 & 3). I will present there one solution we built, which will help a lot in that direction - among others! #environmental #sustainability #shipments #clinical #samples #Novartis
In the upcoming 4th EU Sample Management Symposium on June 20th in Frankfurt, Germany, industry experts will share key insights on the future of sample management. The morning session will be led by Dr. Patrick R. Merz (BASF), Orkun Ozhelvaci (BioNTech) and Neil Gow (UCB Pharma). The afternoon session will be presented by Xavier Briand and Dr. Luc Alexis Leuthold, both from Novartis. For more information on their talks and the Symposium, and to register, visit https://lnkd.in/ezNG6sv7. #SLAS2024 #SampleManagement #Biotech #Pharma
To view or add a comment, sign in
-
Global Life Science Leader, 19+ Years in the Life Science Industry, Strategic Executor, Commercial Excellence, STEM advocate, Girl Mum, Wife, Daughter, Sister, Friend and Mentor.
We all know the importance of Sample Management. Why not join #Avantor next week at our 4th EU Sample Management Symposium?! See below for more details and the links to register - see you there !! #Pharma #biotech #Avantorsetsscienceinmotion #SLAS2024
In the upcoming 4th EU Sample Management Symposium on June 20th in Frankfurt, Germany, industry experts will share key insights on the future of sample management. The morning session will be led by Dr. Patrick R. Merz (BASF), Orkun Ozhelvaci (BioNTech) and Neil Gow (UCB Pharma). The afternoon session will be presented by Xavier Briand and Dr. Luc Alexis Leuthold, both from Novartis. For more information on their talks and the Symposium, and to register, visit https://lnkd.in/ezNG6sv7. #SLAS2024 #SampleManagement #Biotech #Pharma
To view or add a comment, sign in
-
Insights from Day Three of the BIO International Convention in San Diego: https://ow.ly/IrAp50SkhrX. Included in this installment of Scrip’s daily notebook of noteworthy intelligence from the BIO International Convention: • Amgen CEO Bob Bradway taking aim at the "Innovation Reduction Act" • Novo Nordisk's business development head discussing spending its semaglutide bounty • Roivant Sciences's long view on BD prospects for Immunovant's FcRn inhibitor • More regulatory concerns around artificial intelligence #ArtificialIntelligence #InnovationReductionAct #Pharma #Biotech #BIOInternationalConvention
To view or add a comment, sign in
-
Our colleagues Alicja, Karol, Alexander and Aleksandra are attending today the 9th RSC-BMCS Fragment-based Drug Discovery Meeting in Cambridge. Make sure to catch up with them and learn more about our vast portfolio of services that can support your drug discovery processes. #drugdiscovery #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology
To view or add a comment, sign in
-
Time and money are precious—save both with MAbSilico! 💰 Skip the back-and-forth optimization of hits and start immediately with lead candidates ready for development. Maximize efficiency and minimize costs in your antibody discovery journey. 🌐 mabsilico.com #DrugDesign #DrugDiscovery #BioTechs #Pharma #Insilico
To view or add a comment, sign in
-
In a recent survey gathering 206 responses from industry leaders, we uncovered fascinating insights into 32 distinct RBQM practices. More than half of sponsors and CROs have already embraced RBQM approaches, signaling a transformative shift in how we manage risks in drug development. In our latest webinar featuring Ken Getz of Tufts Center for the Study of Drug Development, we explored these numbers. Now, you can watch on-demand: https://bit.ly/440BWmf 🗣 #ClinicalResearch #RBQM #Pharma #Biotech
To view or add a comment, sign in
3,300 followers